Here are three things to know:
1. The donor had no relevant medical history linked to the outcome of the recipients’ transplants. The recipients received the donor’s kidneys, lungs, liver and heart. The heart recipient died from sepsis six months after the transplant.
2. The four other recipients developed a similar type of breast cancer 16 months to 6 years after their organ transplants.
3. Three of these recipients died from cancer complications. The fourth is in remission after undergoing chemotherapy.
“This extraordinary case points out the often fatal consequences of donor-derived breast cancer and suggests that removal of the donor organ and restoration of immunity can induce complete remission,” the study authors concluded.
More articles on clinical leadership and infection control:
Ebola patient rejects treatment, flees to city of 1M in Congo
Time in ICU doubles length of hospital stay for pneumonia patients
5 stats on hospital suicides
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.